Smith+Nephew announces strong performance results for joint replacement technology

Global medical technology company Smith+Nephew’s OXINIUM technology has shown strong performance measures in hip and knee arthroplasties.

Advertisement

OXINIUM is made with zirconium alloy that transforms into ceramicised metal through oxidation for enhanced performance, according to an Aug. 30 news release.

Using four national and regional joint registries with more than 2 million procedures over the past 20 years, the company found that its joint replacement technology showed the lowest risk of revision at 10 years for hip arthroplasties and high survivorship in total knee arthroplasty.

Smooth+Nephew also reported that its OXINIUM technology is associated with increased savings and lower readmission rates.

Advertisement

Next Up in Spinal Tech

  • Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

  • Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know:…

Advertisement

Comments are closed.